SCHEMBL13361985

SCHEMBL13361985

CCC(C)[C@@H](CO)N(C)S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA3 P07451 1/20 0.50
CA4 P22748 1/20 0.50
CA6 P23280 1/20 0.50
CA5A P35218 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
CA13 Q8N1Q1 1/20 0.50
CA14 Q9ULX7 1/20 0.50
CA5B Q9Y2D0 1/20 0.50
PSEN1 P49768 14/20 0.45
PSEN2 P49810 14/20 0.45
APH1B Q8WW43 14/20 0.45
NCSTN Q92542 14/20 0.45
APH1A Q96BI3 14/20 0.45
PSENEN Q9NZ42 14/20 0.45
ADAMTS5 Q9UNA0 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3186389 1.00 CA12 (0.50) CA12CA1CA2CA3CA4
SCHEMBL3199398 0.81 PSEN1 (0.59) CA12CA1CA2CA3CA4
SCHEMBL3185840 0.79 PSEN1 (0.45) CA12CA1CA2CA3CA4
SCHEMBL3179699 0.78 PSEN1 (0.45) CA12CA1CA2CA3CA4
SCHEMBL2337848 0.77 PSEN1 (0.50) CA12CA1CA2CA3CA4
SCHEMBL2337853 0.77 PSEN1 (0.50) CA12CA1CA2CA3CA4
SCHEMBL3188980 0.76 PSEN1 (0.44) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL3198148 0.75 PSEN1 (0.45) CA12CA1CA2CA9PSEN1
SCHEMBL3178164 0.74 CNR1 (0.44) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL3177085 0.74 PSEN1 (0.55) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100120725-A1 Substituted Phenylsulfonamide Inhibitors of Beta Amyloid Production WYETH LLC (US) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120725-A1 Substituted Phenylsulfonamide Inhibitors of Beta Amyloid Production APP, BACE1, PSEN1 CA12 4351/4885CA1 1302/4885CA2 3420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.